Literature DB >> 20732959

Increased blood pressure and hyperdynamic cardiovascular responses in carriers of a common hyperfunctional variant of adenylyl cyclase 6.

Gary J Hodges1, Robert Gros, Robert A Hegele, Stan Van Uum, J Kevin Shoemaker, Ross D Feldman.   

Abstract

Adenylyl cyclase (ADCY) is a critical regulator of metabolic and cardiovascular function. We have identified a genetic variant (A674S) in ADCY isoform 6 (ADCY6). Subsequent studies demonstrated that the expression of this ADCY6 variant paralleled an increase in adenylyl cyclase-mediated functions. However, the impact of this hyperfunctional variant on cardiovascular function is unknown. Therefore, we evaluated the hemodynamic profile of carriers of ADCY6 A674S. The association of ADCY6 A674S with anthropometric and hemodynamic parameters was assessed in 364 healthy white subjects. The allele encoding this variant was present in 6.9% of the subjects, and those individuals had increased blood pressure. To determine the hemodynamic basis for increased blood pressure in carriers of ADCY6 A674S, we assessed forearm blood flow (FBF) and cardiac output at rest, during handgrip exercise (to test vasodilator responsiveness), and with lower body negative pressure [to test forearm vasoconstrictor and heart rate (HR) responsiveness] in a subsample of 21 subjects. At rest, cardiac output and blood pressure were higher in carriers of ADCY6 A674S. This was paralleled by an increase in plasma renin activity, but not in plasma norepinephrine. During handgrip exercise, FBF and vasodilator responses were greater in carriers of ADCY6 A674S. Responses to reactive hyperemia were not different between genotypes. With lower body negative pressure, the HR response to this orthostatic stress was markedly higher in carriers of ADCY6 A674S. These data indicate that the relatively common hyperfunctional ADCY6 A674S variant underlies a hyperdynamic cardiovascular response and increased blood pressure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20732959     DOI: 10.1124/jpet.110.172700

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

Review 1.  Choreographing the adenylyl cyclase signalosome: sorting out the partners and the steps.

Authors:  Rennolds S Ostrom; Amy S Bogard; Robert Gros; Ross D Feldman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-10-20       Impact factor: 3.000

2.  Adenylyl cyclase 6 is required for maintaining acid-base homeostasis.

Authors:  Søren Brandt Poulsen; Caralina Marin De Evsikova; Sathish Kumar Murali; Jeppe Praetorius; Yijuang Chern; Robert A Fenton; Timo Rieg
Journal:  Clin Sci (Lond)       Date:  2018-08-30       Impact factor: 6.124

3.  A common hypofunctional genetic variant of GPER is associated with increased blood pressure in women.

Authors:  Ross D Feldman; Robert Gros; Qingming Ding; Yasin Hussain; Matthew R Ban; Adam D McIntyre; Robert A Hegele
Journal:  Br J Clin Pharmacol       Date:  2014-12       Impact factor: 4.335

4.  Methamphetamine and HIV-Tat alter murine cardiac DNA methylation and gene expression.

Authors:  Christopher A Koczor; Earl Fields; Mark J Jedrzejczak; Zhe Jiao; Tomika Ludaway; Rodney Russ; Joan Shang; Rebecca A Torres; William Lewis
Journal:  Toxicol Appl Pharmacol       Date:  2015-08-22       Impact factor: 4.219

Review 5.  Revisiting cAMP signaling in the carotid body.

Authors:  Ana R Nunes; Andrew P Holmes; Sílvia V Conde; Estelle B Gauda; Emília C Monteiro
Journal:  Front Physiol       Date:  2014-10-28       Impact factor: 4.566

6.  Prognosis and regulation of an adenylyl cyclase network in acute myeloid leukemia.

Authors:  Si-Liang Chen; Fang Hu; Da-Wei Wang; Zhe-Yuan Qin; Yang Liang; Yu-Jun Dai
Journal:  Aging (Albany NY)       Date:  2020-06-22       Impact factor: 5.682

7.  Circ-HIPK3 Strengthens the Effects of Adrenaline in Heart Failure by MiR-17-3p - ADCY6 Axis.

Authors:  Yunfei Deng; Jun Wang; Guojin Xie; Xiaochen Zeng; Hongli Li
Journal:  Int J Biol Sci       Date:  2019-09-07       Impact factor: 6.580

8.  Systems genetics analysis defines importance of TMEM43/LUMA for cardiac- and metabolic-related pathways.

Authors:  Qingqing Gu; Fuyi Xu; Buyan-Ochir Orgil; Zaza Khuchua; Undral Munkhsaikhan; Jason N Johnson; Neely R Alberson; Joseph F Pierre; Dennis D Black; Deli Dong; Jaclyn A Brennan; Brianna M Cathey; Igor R Efimov; Jeffrey A Towbin; Enkhsaikhan Purevjav; Lu Lu
Journal:  Physiol Genomics       Date:  2021-11-12       Impact factor: 3.107

Review 9.  Heart Disease in Women: Unappreciated Challenges, GPER as a New Target.

Authors:  Ross D Feldman
Journal:  Int J Mol Sci       Date:  2016-05-18       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.